These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36059919)

  • 1. Demographic, clinical, and outcome characteristics of carbapenem-resistant Enterobacteriaceae over a 10-year period (2010-2020) in Oman.
    Khamis F; Al-Zakwani I; Molai M; Mohsin J; Al Dowaiki S; Al Bahrani M; Petersen E
    IJID Reg; 2022 Sep; 4():165-170. PubMed ID: 36059919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant
    Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
    Front Public Health; 2022; 10():983174. PubMed ID: 36091556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
    Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.
    Lin Q; Wang Y; Yu J; Li S; Zhang Y; Wang H; Lai X; Liu D; Mao L; Luo Y; Tang G; Chen Z; Sun Z
    BMC Infect Dis; 2021 Jul; 21(1):638. PubMed ID: 34215214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
    Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Risk Factors of Carbapenem-resistant
    Kang JS; Yi J; Ko MK; Lee SO; Lee JE; Kim KH
    J Korean Med Sci; 2019 May; 34(18):e140. PubMed ID: 31074254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Seo H; Lee SC; Chung H; Ra SH; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Chong YP
    Int J Antimicrob Agents; 2020 Oct; 56(4):106126. PubMed ID: 32755654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
    Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M
    Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
    Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.
    Lee NY; Tsai CS; Syue LS; Chen PL; Li CW; Li MC; Ko WC
    Clin Ther; 2020 Mar; 42(3):e33-e44. PubMed ID: 32061374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].
    Bian W; Chen W; Gu X; Wang S; Liu Y; Zhao G; Qin Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1324-1330. PubMed ID: 33463491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant
    Wang X; Wang Q; Cao B; Sun S; Zhang Y; Gu B; Li B; Liao K; Zhao F; Jin L; Jin C; Yang C; Pei F; Zhang Z; Wang H
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    Ara-Montojo MF; Escosa-García L; Alguacil-Guillén M; Seara N; Zozaya C; Plaza D; Schuffelmann-Gutiérrez C; de la Vega Á; Fernández-Camblor C; Ramos-Boluda E; Romero-Gómez MP; Ruiz-Carrascoso G; Losantos-García I; Mellado-Peña MJ; Gómez-Gil R
    J Antimicrob Chemother; 2021 Jan; 76(1):220-225. PubMed ID: 33038895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
    Nabarro LEB; Shankar C; Pragasam AK; Mathew G; Jeyaseelan V; Veeraraghavan B; Verghese VP
    Pediatr Infect Dis J; 2017 Jun; 36(6):e161-e166. PubMed ID: 28005691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem-Resistant
    Madney Y; Aboubakr S; Khedr R; Hafez H; Ahmed N; Elsheshtawy K; Elanany M; Salahelden A; Shalaby L; Galal Behairy O
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant
    Zhu Y; Xiao T; Wang Y; Yang K; Zhou Y; Luo Q; Shen P; Xiao Y
    Infect Drug Resist; 2021; 14():5385-5393. PubMed ID: 34938086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.